Schedule Appointment
Understanding Spravato: A Breakthrough in Depression Treatment
Depression can be stubborn. Many people do “all the right things” and still feel stuck, even after trying therapy, lifestyle changes, and multiple medications. When symptoms refuse to lift or come roaring back, it can start to feel personal, like you failed treatment. You did not.
SPRAVATO is one of the most meaningful additions to depression care in years because it offers a different biological approach and can work on a faster timeline than traditional antidepressants for some patients. It is not a fit for everyone, and it is not a quick fix. Still, for people living with treatment-resistant depression, it can open a door that previously did not exist.
What Spravato is (and why it is different)
Spravato is the brand name for esketamine, a nasal spray used for certain forms of depression. Esketamine is related to ketamine and ketamine therapy, but it is a specifically purified form and is FDA-approved for defined indications when used alongside an oral antidepressant.
Most antidepressants on the market target serotonin, norepinephrine, and dopamine systems. Spravato works differently, acting on glutamate pathways in the brain (often described in terms of NMDA receptor activity and downstream effects). That difference matters because it means people who did not respond to “standard” medication strategies may still respond to Spravato.
Another key difference is how it is delivered as a nasal spray and monitored. Spravato is not picked up at a retail pharmacy and used at home. It is administered in a certified medical setting under a safety program called REMS (Risk Evaluation and Mitigation Strategy), with observation afterward.
Who Spravato may be for
Spravato is generally considered when depression has been persistent and impairing despite adequate trials of antidepressants. It may also be used for major depressive disorder with acute suicidal thoughts or behaviors in some circumstances, as part of a broader treatment plan.
A clinician will look at your symptom history, prior treatments, current medications, medical conditions, and whether you have a prescription for Spravato and safety factors before recommending Spravato. If it is appropriate, the plan also includes an oral antidepressant.
People commonly ask whether they “have to be at rock bottom” to qualify. No, the efficacy of Spravato is considered based on the severity and persistence of symptoms rather than an absolute state of despair. The goal is not to wait until things are unbearable. The goal is to match the intensity of treatment to the severity and persistence of symptoms.
After a thorough evaluation, Spravato may be considered when you are dealing with patterns like:
Long-term depression that does not respond
Relapses after multiple medication trials
Severe symptoms affecting school, work, or relationships
Depression with prominent hopelessness or slowed thinking
What a Spravato visit typically feels like
A Spravato appointment is structured and predictable, which many patients find reassuring after months or years of trial and error. You arrive, check in, and a clinical team confirms you are medically ready for treatment that day. Blood pressure is usually checked before dosing.
You self-administer the nasal spray under supervision. Then you rest in a comfortable, monitored setting for observation. Most clinics plan for at least two hours of monitoring after the dose.
The experience during observation varies, and clinicians may use the MADRS scale to assess changes in depression symptoms. Some people feel noticeably calmer after receiving spravato. Some feel sleepy. Some feel “floaty” or detached. Some people feel very little in the moment, and changes show up over the next day or two. Many clinics encourage quiet activities, like listening to music, resting, or guided relaxation.
Because judgment and coordination can be affected afterward, you will need a ride home. You cannot drive yourself after treatment, even if you feel fine.
Time commitment and dosing schedule
Spravato is not a one-time procedure. It is a course of treatment with an induction phase and a maintenance phase. The schedule can shift based on response, side effects, and clinical judgment.
Below is a common framework that many programs follow, though your plan may differ.
Phase
Typical frequency
What the goal is
Induction (Weeks 1 to 4)
2 visits per week
Kick-start symptom relief, assess tolerability, adjust dose if needed
Early maintenance (Weeks 5 to 8)
1 visit per week
Stabilize gains and reduce risk of quick relapse
Ongoing maintenance (Week 9 and beyond)
Every 2 weeks or individualized
Maintain progress with the lowest effective frequency
It also helps to plan around the “hidden” time: transportation, time off work or school, and taking it easy for the remainder of the day.
Benefits and realistic expectations
Spravato is often described as “fast-acting,” and some people do notice changes quickly, sometimes within days, which underscores the importance of evaluating its efficacy using scales like MADRS. Still, the response is not universal, and improvements may be gradual. Some patients notice that suicidal thinking quiets before mood improves. Others report better sleep or less emotional heaviness before motivation returns.
It can help to define what “working” looks like in your life. For many people, early signs include:
Less time stuck in rumination
A bit more mental energy
Improved ability to engage in therapy
Reduced intensity of hopeless thoughts
More consistent daily functioning
Response also depends on the rest of the plan. Spravato is usually most helpful when paired with ongoing medication management, prescription ketamine therapy, and supportive therapy that targets sleep, stress, drowsiness, trauma, relationships, and habits that depression disrupts.
Safety, side effects, and why monitoring matters
The two-hour monitoring period is not just a formality. Spravato can temporarily raise blood pressure, and it can cause dissociation, sedation, dizziness, nausea, or a sense of altered perception, similar to effects experienced with some nasal sprays used for medication delivery. These effects typically peak soon after dosing and fade as the observation period ends, but the timeline varies.
The REMS program exists to reduce risks and make sure Spravato is given in the right setting, to the right patients, with consistent follow-up. Your clinic should also review medication interactions and substance use history, since those factors can change the safety picture.
After reviewing your medical history, your clinician may talk through topics like:
Dissociation and perceptual changes: Feeling detached, spacey, or unusual sensory shifts during the observation window.
Sleepiness and slowed reaction time: The reason driving is not allowed afterward and why many people rest for the remainder of the day.
Blood pressure increases: Typically temporary, monitored before and after dosing, with extra caution for people with certain cardiovascular risks.
Nausea, dizziness, or drowsiness: Often manageable, sometimes improved with hydration, light meals, or dose adjustments.
Misuse risk considerations with Spravato: Screenings and safeguards are part of responsible prescribing, especially if there is a history of substance misuse.
If you are pregnant, planning pregnancy, or managing complex medical conditions, your clinician will weigh risks and alternatives carefully. The right plan is always individualized.
How Spravato fits into a full depression care plan
Spravato, similar to ketamine therapy, is not meant to replace the basics of good psychiatric care, but its efficacy in enhancing treatment outcomes is notable, and it is often administered alongside other treatments such as a nasal spray. Think of it as one tool that can make other tools work better.
Many people find that as symptoms soften, therapy becomes more productive. It becomes easier to challenge negative beliefs, practice coping skills, repair routines, and re-engage socially. Medication management also remains important, including the oral antidepressant prescription used alongside Spravato and any other medications supporting sleep, anxiety, focus, or mood stability.
It is also a good time to review contributing factors that can keep depression “stuck,” including:
untreated anxiety or panic
trauma-related symptoms
alcohol or cannabis use patterns that worsen mood over time
sleep apnea or chronic insomnia
thyroid or hormone-related concerns
ADHD symptoms that complicate depression recovery
Integrated clinics that combine psychiatric care with wellness services can be especially helpful here, since depression rarely lives in just one compartment of health.
Planning care in Georgia: access, insurance, and logistics
Spravato treatment requires in-person visits to a certified site, even if much of your other care can happen via telepsychiatry. Many patients use a hybrid approach: virtual check-ins for medication management and in-person appointments for dosing days.
Insurance coverage varies by plan, and prior authorization is common. If you are considering Spravato, it helps to ask a clinic these practical questions early:
Do you accept my insurance, including Medicare or Georgia Medicaid plans?
What documentation is needed to show treatment resistance?
How soon can I be evaluated and, if appropriate, start treatment?
What are my responsibilities for transportation and after-care?
At Next Step Psychiatry in Lilburn, Georgia, patients often look for a clinic that can coordinate these pieces under one team: psychiatric evaluations, ongoing medication management, and FDA-approved Spravato for treatment-resistant depression, with both in-person care and telepsychiatry options across Georgia where appropriate. If you are exploring Spravato, asking for a clear plan, expected timeline, and a realistic view of costs and scheduling can make the process feel far more manageable.
Depression can narrow your sense of what is possible. When a new treatment is on the table, it is normal to feel hopeful and cautious at the same time. A careful evaluation, including the use of tools such as the MADRS, a structured monitoring process, and a personalized plan for the weeks ahead can help you decide whether Spravato is the next sensible step for you.
